Name
RECOMBINANT HUMAN ERYTHROPOIETIN
Mode of Action
IT IS A HEMATOPOIETIC GROWTH FACTOR.IT REGULATES ERYTHROPOIESIS BY STIMULATING THE DIFFERENTIATION AND PROLIFERATION OF ERYTHROID PRECUSORS, STIMULATING THE RELEASE OF RETICULOCYTES INTO THE CIRCULATION AND STIMULATING THE SYNTHESIS OF CELLULAR HAEMOGLOBIN.
Dosage
INITIALLY 25-50 IU/KG I.V. OVER 1-2 MINUTES, 3 TIMES/WEEK. DOSE INCREMENT IN STEPS OF 25 IU/KG IN INTERVALS OF 4 WEEKS, DEPENDING UPON INITIAL RESPONSE. MAINTENENCE DOSE WEEKLY- 100-300 IU/KG IN 2-3 INJECTIONS.
Drug Group
[HAEMATOPOIETIC GROWTH FACTOR] , [RECOMBINANT HUMAN ERYTHROPOIETIN]
Cross Reaction
INCREASED DOSE OF HEPARIN IS NEEDED IN ITS PRESENCE. HAEMATENICS ENHANCE ITS EFFICIENCY.
Drug Interaction
Drugs Side Effect
Drug Categories
Special Precaution
Drug Safety
Monograph